Articles
Nativis’ platform aims to transform disease treatment on a global scale – “a symphony of cures”
In late 2015, I was approached by the board of Nativis, Inc.to take on the leadership of the company, by then a 13-year-old “startup.”
I...
News
Medley Genomics and Transformative AI Selected as Winners in the 2017 Pistoia Alliance President’s Startup Challenge
The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, today announced the winners...
News
The Netherlands Cancer Institute Awarded Funding to Apply Molecular Imaging Technology to Prostate Cancer Surgery
The Netherlands Cancer Institute (NKI) announced that it has received funding from the Dutch Cancer Society (KWF Kankerbestrijding) to test whether a novel molecular...
Drug Research
ANTABIO Raises € 7.3M Series A Financing to Develop Novel Treatments against Drug-Resistant Gram-Negative Infections
Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today the completion of a €7.3M series. ...
News
Clinerion adds FHIR data model to its set of standard electronic medical record formats
Clinerion announces that data integration to its Patient Recruitment System platform can now also process electronic medical records made available by hospitals using the...
Production & Manufacturing
Batavia Biosciences Expands its Viral Vector and GMP Facilities to Accommodate Increasing Market Demand
Batavia Biosciences announces the expansion of its viral vector process development facilities in the USA and its GMP clean room facilities in the Netherlands...
Clinical Trials
Chi-Med Reports Preliminary Phase II data on Fruquintinib Combination in First-Line Lung Cancer
Hutchison China MediTech Limited reported preliminary clinical activity, safety, and tolerability data of fruquintinib, an investigational selective inhibitor of vascular endothelial growth factor receptor...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read